Concepts (289)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Amblyopia | 14 | 2024 | 150 | 6.230 |
Why?
|
Optic Neuropathy, Ischemic | 9 | 2023 | 86 | 4.860 |
Why?
|
Optic Disk | 7 | 2019 | 421 | 2.380 |
Why?
|
Fluorescein Angiography | 10 | 2022 | 1059 | 2.290 |
Why?
|
Copper | 6 | 2014 | 369 | 2.180 |
Why?
|
Tomography, Optical Coherence | 12 | 2022 | 2917 | 2.170 |
Why?
|
Visual Acuity | 19 | 2024 | 2672 | 1.990 |
Why?
|
Retinal Vessels | 6 | 2021 | 852 | 1.900 |
Why?
|
Mixed Function Oxygenases | 5 | 2014 | 265 | 1.680 |
Why?
|
Giant Cell Arteritis | 3 | 2022 | 306 | 1.590 |
Why?
|
Pseudotumor Cerebri | 3 | 2023 | 108 | 1.540 |
Why?
|
Papilledema | 3 | 2023 | 130 | 1.480 |
Why?
|
Multienzyme Complexes | 5 | 2014 | 666 | 1.430 |
Why?
|
Ciliary Arteries | 3 | 2021 | 19 | 1.360 |
Why?
|
Retinal Diseases | 3 | 2021 | 705 | 1.330 |
Why?
|
Vision Disorders | 7 | 2024 | 1088 | 1.310 |
Why?
|
Retinal Artery Occlusion | 2 | 2021 | 77 | 1.280 |
Why?
|
Optic Nerve Diseases | 3 | 2023 | 342 | 1.170 |
Why?
|
Retinal Artery | 2 | 2017 | 109 | 1.080 |
Why?
|
Ophthalmology | 4 | 2022 | 550 | 1.060 |
Why?
|
Amygdala | 4 | 2014 | 1354 | 0.980 |
Why?
|
Vision, Low | 2 | 2024 | 163 | 0.930 |
Why?
|
Autistic Disorder | 2 | 2024 | 1220 | 0.920 |
Why?
|
Choroid Diseases | 2 | 2022 | 63 | 0.900 |
Why?
|
Accommodation, Ocular | 1 | 2024 | 47 | 0.900 |
Why?
|
Eye Injuries | 2 | 2024 | 227 | 0.900 |
Why?
|
Remission, Spontaneous | 1 | 2024 | 384 | 0.890 |
Why?
|
Oculomotor Nerve Diseases | 1 | 2024 | 54 | 0.880 |
Why?
|
Strabismus | 3 | 2024 | 317 | 0.870 |
Why?
|
Esotropia | 1 | 2024 | 99 | 0.820 |
Why?
|
Video Games | 2 | 2023 | 198 | 0.800 |
Why?
|
Meningitis, Cryptococcal | 1 | 2022 | 67 | 0.770 |
Why?
|
Eye Injuries, Penetrating | 2 | 2022 | 124 | 0.760 |
Why?
|
Child Abuse, Sexual | 1 | 2024 | 403 | 0.750 |
Why?
|
Orbital Myositis | 1 | 2021 | 25 | 0.740 |
Why?
|
Optic Disk Drusen | 2 | 2019 | 38 | 0.740 |
Why?
|
Diagnostic Techniques, Ophthalmological | 3 | 2020 | 251 | 0.730 |
Why?
|
Coloboma | 2 | 2018 | 59 | 0.720 |
Why?
|
Visual Fields | 5 | 2018 | 1062 | 0.720 |
Why?
|
Choroid | 2 | 2022 | 360 | 0.710 |
Why?
|
Eye Diseases | 2 | 2023 | 653 | 0.710 |
Why?
|
Fovea Centralis | 1 | 2021 | 126 | 0.710 |
Why?
|
Duane Retraction Syndrome | 1 | 2021 | 59 | 0.710 |
Why?
|
Muscle Spasticity | 1 | 2021 | 156 | 0.700 |
Why?
|
Intracranial Hypertension | 1 | 2022 | 193 | 0.700 |
Why?
|
Spinocerebellar Ataxias | 1 | 2021 | 105 | 0.690 |
Why?
|
Scotoma | 2 | 2017 | 130 | 0.670 |
Why?
|
Microvessels | 2 | 2021 | 577 | 0.660 |
Why?
|
Chorea | 1 | 2020 | 79 | 0.660 |
Why?
|
Optic Atrophy | 1 | 2020 | 79 | 0.660 |
Why?
|
Optic Atrophy, Hereditary, Leber | 2 | 2016 | 50 | 0.650 |
Why?
|
Zinc | 2 | 2014 | 690 | 0.640 |
Why?
|
Vision, Ocular | 2 | 2021 | 455 | 0.640 |
Why?
|
Vitreous Body | 1 | 2020 | 399 | 0.620 |
Why?
|
Orbital Fractures | 1 | 2019 | 109 | 0.620 |
Why?
|
Optic Nerve Neoplasms | 1 | 2018 | 45 | 0.600 |
Why?
|
Metabolism, Inborn Errors | 1 | 2020 | 284 | 0.580 |
Why?
|
Anophthalmos | 1 | 2017 | 23 | 0.570 |
Why?
|
Synaptic Transmission | 3 | 2014 | 1173 | 0.570 |
Why?
|
Spastic Paraplegia, Hereditary | 1 | 2020 | 168 | 0.570 |
Why?
|
Neuromyelitis Optica | 1 | 2021 | 264 | 0.560 |
Why?
|
Angiography | 2 | 2022 | 1595 | 0.550 |
Why?
|
Retinal Telangiectasis | 1 | 2016 | 25 | 0.540 |
Why?
|
Conjunctival Neoplasms | 1 | 2017 | 77 | 0.530 |
Why?
|
Oculomotor Muscles | 4 | 2024 | 406 | 0.520 |
Why?
|
Retinal Vein Occlusion | 1 | 2017 | 149 | 0.510 |
Why?
|
Carotid Artery Diseases | 1 | 2021 | 877 | 0.490 |
Why?
|
Human papillomavirus 16 | 1 | 2017 | 267 | 0.490 |
Why?
|
Visual Field Tests | 4 | 2018 | 411 | 0.490 |
Why?
|
Retina | 3 | 2022 | 2659 | 0.480 |
Why?
|
Homozygote | 1 | 2020 | 1776 | 0.480 |
Why?
|
Lyme Disease | 1 | 2021 | 631 | 0.480 |
Why?
|
GTP Phosphohydrolases | 1 | 2017 | 517 | 0.450 |
Why?
|
Optic Nerve | 1 | 2017 | 572 | 0.450 |
Why?
|
Vision, Binocular | 4 | 2024 | 226 | 0.450 |
Why?
|
Recovery of Function | 1 | 2024 | 2979 | 0.450 |
Why?
|
Conjunctiva | 1 | 2017 | 479 | 0.440 |
Why?
|
Optic Neuritis | 1 | 2015 | 174 | 0.440 |
Why?
|
Hemangioma | 1 | 2018 | 727 | 0.420 |
Why?
|
Diplopia | 3 | 2024 | 214 | 0.420 |
Why?
|
Ophthalmologic Surgical Procedures | 3 | 2024 | 354 | 0.400 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2022 | 2872 | 0.400 |
Why?
|
Sensory Deprivation | 3 | 2023 | 108 | 0.390 |
Why?
|
Humans | 60 | 2024 | 761596 | 0.360 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2022 | 1640 | 0.360 |
Why?
|
Nerve Fibers | 3 | 2019 | 708 | 0.350 |
Why?
|
Eye | 3 | 2023 | 712 | 0.340 |
Why?
|
Interneurons | 1 | 2013 | 593 | 0.310 |
Why?
|
Fear | 2 | 2014 | 1477 | 0.300 |
Why?
|
Neuronal Plasticity | 4 | 2022 | 1436 | 0.300 |
Why?
|
Proteins | 2 | 2020 | 6032 | 0.290 |
Why?
|
Antibodies, Viral | 1 | 2017 | 3156 | 0.260 |
Why?
|
Arteritis | 2 | 2018 | 158 | 0.250 |
Why?
|
Papillomavirus Infections | 1 | 2017 | 1613 | 0.240 |
Why?
|
Mutation | 5 | 2021 | 30053 | 0.240 |
Why?
|
Genetic Testing | 2 | 2017 | 3537 | 0.240 |
Why?
|
Recurrence | 3 | 2024 | 8466 | 0.240 |
Why?
|
Miosis | 1 | 2024 | 9 | 0.240 |
Why?
|
Synapses | 4 | 2017 | 1769 | 0.230 |
Why?
|
Capillaries | 2 | 2017 | 755 | 0.220 |
Why?
|
Exotropia | 1 | 2024 | 64 | 0.220 |
Why?
|
Abducens Nerve Diseases | 1 | 2023 | 44 | 0.210 |
Why?
|
Long-Term Potentiation | 2 | 2014 | 293 | 0.200 |
Why?
|
Male | 24 | 2024 | 360846 | 0.200 |
Why?
|
Orthoptics | 1 | 2021 | 10 | 0.200 |
Why?
|
Vitreoretinopathy, Proliferative | 1 | 2022 | 76 | 0.200 |
Why?
|
Muscular Dystrophy, Emery-Dreifuss | 1 | 2021 | 21 | 0.190 |
Why?
|
Retinal Ganglion Cells | 2 | 2017 | 811 | 0.190 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2017 | 4024 | 0.190 |
Why?
|
Cation Transport Proteins | 2 | 2014 | 327 | 0.190 |
Why?
|
DNA, Mitochondrial | 2 | 2017 | 865 | 0.180 |
Why?
|
Female | 23 | 2024 | 392705 | 0.180 |
Why?
|
Child, Preschool | 8 | 2024 | 42232 | 0.180 |
Why?
|
Blepharoptosis | 1 | 2021 | 144 | 0.170 |
Why?
|
Eye Evisceration | 1 | 2019 | 22 | 0.170 |
Why?
|
Eye Enucleation | 1 | 2019 | 128 | 0.170 |
Why?
|
Child | 11 | 2024 | 80158 | 0.170 |
Why?
|
Adenosine Triphosphatases | 2 | 2014 | 836 | 0.170 |
Why?
|
Carotid Artery, Internal | 1 | 2021 | 445 | 0.160 |
Why?
|
Bone Density | 1 | 2012 | 3551 | 0.160 |
Why?
|
Health Status | 1 | 2012 | 4077 | 0.160 |
Why?
|
Orbit | 1 | 2022 | 457 | 0.160 |
Why?
|
Uveal Diseases | 1 | 2018 | 45 | 0.160 |
Why?
|
Emotions | 1 | 2010 | 2739 | 0.160 |
Why?
|
Eyelids | 1 | 2021 | 278 | 0.160 |
Why?
|
Middle Aged | 13 | 2022 | 220921 | 0.150 |
Why?
|
Diagnosis, Differential | 4 | 2024 | 12973 | 0.150 |
Why?
|
Pupil Disorders | 1 | 2018 | 32 | 0.150 |
Why?
|
Retinal Detachment | 1 | 2022 | 428 | 0.150 |
Why?
|
Glutarates | 1 | 2020 | 243 | 0.150 |
Why?
|
Edema | 1 | 2022 | 766 | 0.150 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12149 | 0.150 |
Why?
|
Osteomyelitis | 1 | 2021 | 407 | 0.150 |
Why?
|
Muscle Relaxants, Central | 1 | 2018 | 93 | 0.140 |
Why?
|
Patch-Clamp Techniques | 4 | 2014 | 927 | 0.140 |
Why?
|
Aged | 10 | 2022 | 169310 | 0.140 |
Why?
|
Heterozygote | 2 | 2014 | 2787 | 0.140 |
Why?
|
Walking | 1 | 2024 | 1198 | 0.140 |
Why?
|
Corneal Diseases | 1 | 2022 | 542 | 0.140 |
Why?
|
Arterioles | 1 | 2017 | 250 | 0.140 |
Why?
|
Ophthalmoscopy | 1 | 2017 | 171 | 0.140 |
Why?
|
Dilatation, Pathologic | 1 | 2017 | 527 | 0.130 |
Why?
|
Fundus Oculi | 1 | 2017 | 556 | 0.130 |
Why?
|
Optic Atrophy, Autosomal Dominant | 1 | 2015 | 8 | 0.130 |
Why?
|
Siblings | 1 | 2020 | 825 | 0.130 |
Why?
|
Follow-Up Studies | 6 | 2024 | 39106 | 0.130 |
Why?
|
Prognosis | 4 | 2022 | 29629 | 0.120 |
Why?
|
Leukemia | 1 | 2023 | 1522 | 0.120 |
Why?
|
Adult | 11 | 2024 | 221210 | 0.120 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2014 | 15936 | 0.120 |
Why?
|
Retrospective Studies | 8 | 2024 | 80647 | 0.120 |
Why?
|
Pentylenetetrazole | 1 | 2014 | 71 | 0.110 |
Why?
|
GABA Antagonists | 1 | 2014 | 120 | 0.110 |
Why?
|
trans-Golgi Network | 1 | 2013 | 33 | 0.110 |
Why?
|
Animals | 11 | 2023 | 168475 | 0.110 |
Why?
|
DNA Mutational Analysis | 2 | 2021 | 4111 | 0.110 |
Why?
|
Tissue Culture Techniques | 1 | 2014 | 290 | 0.100 |
Why?
|
Subcellular Fractions | 1 | 2013 | 532 | 0.100 |
Why?
|
Catecholamines | 1 | 2013 | 386 | 0.100 |
Why?
|
Incidental Findings | 1 | 2017 | 697 | 0.100 |
Why?
|
Hippocampus | 3 | 2014 | 3766 | 0.100 |
Why?
|
Autoantibodies | 1 | 2021 | 2118 | 0.100 |
Why?
|
Brain | 2 | 2024 | 27121 | 0.100 |
Why?
|
Electrophysiology | 3 | 2010 | 1262 | 0.100 |
Why?
|
Pedigree | 1 | 2020 | 4542 | 0.100 |
Why?
|
Pyramidal Cells | 1 | 2014 | 369 | 0.090 |
Why?
|
Mice | 6 | 2023 | 81539 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 3 | 2024 | 36426 | 0.090 |
Why?
|
Hematocrit | 1 | 2012 | 623 | 0.090 |
Why?
|
Mice, Mutant Strains | 1 | 2013 | 1749 | 0.090 |
Why?
|
Secondary Prevention | 1 | 2016 | 1475 | 0.090 |
Why?
|
Neural Inhibition | 1 | 2014 | 590 | 0.090 |
Why?
|
Diazepam | 1 | 2010 | 215 | 0.080 |
Why?
|
Membrane Potentials | 2 | 2010 | 1090 | 0.080 |
Why?
|
Ultrasonography | 2 | 2019 | 5971 | 0.080 |
Why?
|
Signal Transduction | 1 | 2012 | 23447 | 0.080 |
Why?
|
Visual Cortex | 1 | 2017 | 1108 | 0.080 |
Why?
|
DNA Copy Number Variations | 1 | 2017 | 2020 | 0.080 |
Why?
|
Behavior, Animal | 2 | 2014 | 1878 | 0.080 |
Why?
|
Mutation, Missense | 1 | 2017 | 2571 | 0.080 |
Why?
|
Muscle Strength | 1 | 2012 | 624 | 0.070 |
Why?
|
Thalamus | 1 | 2014 | 1047 | 0.070 |
Why?
|
Excitatory Postsynaptic Potentials | 1 | 2008 | 369 | 0.070 |
Why?
|
Mass Spectrometry | 1 | 2014 | 2192 | 0.070 |
Why?
|
Biogenic Amines | 1 | 2006 | 53 | 0.070 |
Why?
|
Pain | 1 | 2022 | 5073 | 0.070 |
Why?
|
Young Adult | 4 | 2021 | 59260 | 0.070 |
Why?
|
Frail Elderly | 1 | 2012 | 765 | 0.070 |
Why?
|
Mice, Inbred C57BL | 3 | 2014 | 22174 | 0.070 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4740 | 0.070 |
Why?
|
Aged, 80 and over | 5 | 2024 | 58984 | 0.070 |
Why?
|
Treatment Outcome | 5 | 2023 | 64685 | 0.060 |
Why?
|
Infant | 3 | 2024 | 36193 | 0.060 |
Why?
|
Glaucoma | 1 | 2015 | 1185 | 0.060 |
Why?
|
DNA | 2 | 2021 | 7213 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 2 | 2019 | 20568 | 0.060 |
Why?
|
Polymerase Chain Reaction | 1 | 2014 | 6075 | 0.060 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2008 | 569 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2010 | 6228 | 0.060 |
Why?
|
Risk Factors | 3 | 2023 | 74213 | 0.060 |
Why?
|
Gap Junctions | 1 | 2006 | 230 | 0.060 |
Why?
|
Triglycerides | 1 | 2012 | 2461 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4062 | 0.060 |
Why?
|
Lichen Planus | 1 | 2024 | 70 | 0.050 |
Why?
|
Nystagmus, Pathologic | 1 | 2024 | 105 | 0.050 |
Why?
|
Acetylcholinesterase | 1 | 2023 | 156 | 0.050 |
Why?
|
Homeostasis | 1 | 2014 | 3323 | 0.050 |
Why?
|
Pattern Recognition, Visual | 1 | 2008 | 823 | 0.050 |
Why?
|
Activities of Daily Living | 1 | 2012 | 2421 | 0.050 |
Why?
|
Telemedicine | 1 | 2020 | 3052 | 0.050 |
Why?
|
Eye Pain | 1 | 2022 | 46 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3086 | 0.050 |
Why?
|
Neurotransmitter Agents | 1 | 2006 | 665 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3206 | 0.050 |
Why?
|
Membrane Proteins | 2 | 2017 | 7859 | 0.050 |
Why?
|
Phenotype | 1 | 2020 | 16592 | 0.050 |
Why?
|
Ion Channels | 1 | 2006 | 1040 | 0.050 |
Why?
|
Mice, Transgenic | 1 | 2014 | 9542 | 0.050 |
Why?
|
Dietary Supplements | 1 | 2014 | 3415 | 0.050 |
Why?
|
Seizures | 1 | 2014 | 2957 | 0.050 |
Why?
|
Mice, Knockout | 2 | 2014 | 14417 | 0.050 |
Why?
|
Multiple Sclerosis | 1 | 2015 | 3222 | 0.040 |
Why?
|
Eyeglasses | 1 | 2021 | 137 | 0.040 |
Why?
|
Cells, Cultured | 2 | 2013 | 18966 | 0.040 |
Why?
|
Genotype | 1 | 2014 | 12990 | 0.040 |
Why?
|
Cerebral Cortex | 2 | 2013 | 5779 | 0.040 |
Why?
|
Disease Progression | 1 | 2016 | 13510 | 0.040 |
Why?
|
Skull Base | 1 | 2021 | 292 | 0.040 |
Why?
|
Lighting | 1 | 2020 | 211 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11076 | 0.030 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2020 | 385 | 0.030 |
Why?
|
Confidentiality | 1 | 2020 | 609 | 0.030 |
Why?
|
Diet | 1 | 2014 | 8075 | 0.030 |
Why?
|
Adolescent | 1 | 2024 | 88326 | 0.030 |
Why?
|
Prostheses and Implants | 1 | 2022 | 1271 | 0.030 |
Why?
|
Anxiety | 1 | 2010 | 4573 | 0.030 |
Why?
|
Cornea | 1 | 2022 | 1333 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2024 | 2161 | 0.030 |
Why?
|
Nerve Net | 1 | 2006 | 2291 | 0.030 |
Why?
|
Documentation | 1 | 2020 | 897 | 0.030 |
Why?
|
Cohort Studies | 2 | 2016 | 41495 | 0.030 |
Why?
|
Pandemics | 2 | 2023 | 8656 | 0.020 |
Why?
|
Pregnancy | 1 | 2013 | 29890 | 0.020 |
Why?
|
Muscles | 2 | 2006 | 1576 | 0.020 |
Why?
|
Managed Care Programs | 1 | 2016 | 940 | 0.020 |
Why?
|
Neurons | 2 | 2008 | 9463 | 0.020 |
Why?
|
Internet | 1 | 2022 | 3093 | 0.020 |
Why?
|
Patient Compliance | 1 | 2020 | 2690 | 0.020 |
Why?
|
Vaccination | 1 | 2021 | 3384 | 0.020 |
Why?
|
Silver Staining | 1 | 2008 | 62 | 0.020 |
Why?
|
Synaptophysin | 1 | 2008 | 139 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8633 | 0.020 |
Why?
|
Prospective Studies | 2 | 2023 | 54423 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3462 | 0.020 |
Why?
|
Exploratory Behavior | 1 | 2008 | 279 | 0.020 |
Why?
|
Palinuridae | 1 | 2006 | 1 | 0.020 |
Why?
|
Avoidance Learning | 1 | 2008 | 248 | 0.020 |
Why?
|
Octopamine | 1 | 2006 | 43 | 0.020 |
Why?
|
Maze Learning | 1 | 2008 | 483 | 0.020 |
Why?
|
Ganglia, Invertebrate | 1 | 2006 | 25 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2020 | 3251 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2008 | 695 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2021 | 5799 | 0.020 |
Why?
|
Cyclic Nucleotide-Gated Cation Channels | 1 | 2006 | 38 | 0.020 |
Why?
|
Dendrites | 1 | 2008 | 475 | 0.020 |
Why?
|
Oscillometry | 1 | 2006 | 150 | 0.020 |
Why?
|
Microelectrodes | 1 | 2006 | 306 | 0.020 |
Why?
|
Biophysical Phenomena | 1 | 2006 | 320 | 0.020 |
Why?
|
Biophysics | 1 | 2006 | 380 | 0.010 |
Why?
|
Algorithms | 2 | 2020 | 14033 | 0.010 |
Why?
|
Potassium Channels | 1 | 2006 | 537 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2008 | 2677 | 0.010 |
Why?
|
Models, Anatomic | 1 | 2006 | 683 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12463 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2006 | 2264 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10774 | 0.010 |
Why?
|
United States | 2 | 2022 | 72340 | 0.010 |
Why?
|
Serotonin | 1 | 2006 | 1041 | 0.010 |
Why?
|
Electric Stimulation | 1 | 2006 | 1736 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 26129 | 0.010 |
Why?
|
Motor Neurons | 1 | 2006 | 870 | 0.010 |
Why?
|
Dopamine | 1 | 2006 | 1607 | 0.010 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2006 | 874 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2006 | 3792 | 0.010 |
Why?
|
Movement | 1 | 2006 | 1478 | 0.010 |
Why?
|
Caenorhabditis elegans | 1 | 2006 | 1456 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2008 | 4415 | 0.010 |
Why?
|
Risk Assessment | 1 | 2015 | 23996 | 0.010 |
Why?
|
Models, Biological | 1 | 2006 | 9469 | 0.010 |
Why?
|
Concepts
(289)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(51)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_